Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.

[1]  A. Elhissi,et al.  Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. , 2012, International journal of pharmaceutics.

[2]  K. Taylor,et al.  High-sensitivity differential scanning calorimetry for measurement of steroid entrapment in nebulised liposomes generated from proliposomes , 2011 .

[3]  K. Taylor,et al.  Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology , 2011, Journal of liposome research.

[4]  Yong Hao,et al.  Entrapment and release difference resulting from hydrogen bonding interactions in niosome. , 2011, International journal of pharmaceutics.

[5]  K. Taylor,et al.  Chitosan‐coated antifungal formulations for nebulisation , 2010 .

[6]  L. Rizza,et al.  Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation , 2010, Drug delivery.

[7]  V. Junyaprasert,et al.  Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes , 2008, AAPS PharmSciTech.

[8]  H. M. El-laithy,et al.  Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. , 2008, International journal of pharmaceutics.

[9]  S. Antimisiaris,et al.  Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  K. Taylor,et al.  The influence of fluid physicochemical properties on vibrating-mesh nebulization. , 2007, International journal of pharmaceutics.

[11]  K. Taylor,et al.  Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. , 2007, International journal of pharmaceutics.

[12]  A. Adin,et al.  Electroflocculation: the effect of zeta-potential on particle size , 2007 .

[13]  K. Taylor,et al.  A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. , 2006, International journal of pharmaceutics.

[14]  K. Taylor,et al.  Formulations generated from ethanol‐based proliposomes for delivery via medical nebulizers , 2006, The Journal of pharmacy and pharmacology.

[15]  M. Carafa,et al.  Non-phospholipid vesicles for pulmonary glucocorticoid delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  H. Schreier,et al.  Nebulization of Liposomes. II. The Effects of Size and Modeling of Solute Release Profiles , 1991, Pharmaceutical Research.

[17]  K. Taylor,et al.  The Influence of Liposomal Encapsulation on Sodium Cromoglycate Pharmacokinetics in Man , 1989, Pharmaceutical Research.

[18]  Abdelbary Elhissi,et al.  Delivery of liposomes generated from proliposomes using air-jet, ultrasonic and vibrating mesh nebulisers , 2004 .

[19]  R. Dhand.  Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. , 2002, Respiratory care.

[20]  W. Finlay,et al.  Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes. , 2002, International journal of pharmaceutics.

[21]  R. Hancock,et al.  In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. , 2001, Journal of pharmaceutical sciences.

[22]  I. Kellaway,et al.  Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. , 2001, International journal of pharmaceutics.

[23]  K. Taylor,et al.  The effects of freeze‐drying on the stability of liposomes to jet nebulization , 2001, The Journal of pharmacy and pharmacology.

[24]  K. Taylor,et al.  The measurement of beclomethasone dipropionate entrapment in liposomes: a comparison of a microscope and an HPLC method. , 2001, International journal of pharmaceutics.

[25]  P. Diot,et al.  Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[26]  D. Rhodes,et al.  Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.

[27]  A. Coates,et al.  Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[28]  V. Turjanmaa,et al.  Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. , 1999, International journal of pharmaceutics.

[29]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[30]  D. Crommelin,et al.  Thermal analysis of freeze-dried liposome-carbohydrate mixtures with modulated temperature differential scanning calorimetry. , 1998, Journal of pharmaceutical sciences.

[31]  D. Crommelin,et al.  Long term stability of freeze-dried, lyoprotected doxorubicin liposomes , 1997 .

[32]  C O'Callaghan,et al.  The science of nebulised drug delivery , 1997, Thorax.

[33]  I. Uchegbu,et al.  Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry , 1995 .

[34]  A. Clark.  The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .

[35]  K. Taylor,et al.  Effect of calcium ions on the surface charge and aggregation of phosphatidylcholine liposomes. , 1995, Journal of drug targeting.

[36]  J. Waldrep,et al.  Nebulized Glucocorticoids in Liposomes: Aerosol Characteristics and Human Dose Estimates , 1994 .

[37]  M. Dahlbäck.  Behavior of nebulizing solutions and suspensions. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[38]  I. Kellaway,et al.  Liposomes as drug delivery systems to the lung , 1990 .

[39]  K. Taylor,et al.  The stability of liposomes to nebulisation , 1990 .

[40]  J. Crowe,et al.  Dry dipalmitoylphosphatidylcholine and trehalose revisited , 1988 .

[41]  P. Timmins,et al.  Proliposomes: a novel solution to an old problem. , 1986, Journal of pharmaceutical sciences.

[42]  D. Crommelin,et al.  Stability of doxorubicin-liposomes on storage: as an aqueous dispersion, frozen or freeze-dried , 1984 .

[43]  D. Crommelin.  Influence of lipid composition and ionic strength on the physical stability of liposomes. , 1984, Journal of pharmaceutical sciences.

[44]  D. Pavia,et al.  ASSESSMENT OF JET NEBULISERS FOR LUNG AEROSOL THERAPY , 1983, The Lancet.

[45]  J. Heyder.  Particle transport onto human airway surfaces. , 1982, European journal of respiratory diseases. Supplement.

[46]  R. Deitch.  Treatment of severely handicapped infants. , 1981, Lancet.